Coherus Biosciences | CHRS - Ebit





Ebit Alterar Data
AbbVie USD 4.73B 1.08B 2026-03
Acadia Pharmaceuticals USD -4.62M 22.01M 2026-03
Akebia Therapeutics USD -5.45M 9.4M 2025-12
ALKERMES USD -48.28M 37.33M 2026-03
Alnylam Pharmaceuticals USD 137.59M 108.19M 2026-03
Amarin USD -2.26M 564K 2025-12
Amgen USD 3.83B 130M 2026-03
Baxter International USD 66M 280.2M 2026-03
Biogen USD 514.3M 502.8M 2026-03
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
Bristol-Myers Squibb USD 3.56B 90M 2026-03
Coherus Biosciences USD -39.08M 3.65M 2025-12
Eli Lilly USD 9.78B 792M 2026-03
Fujifilm JPY 101.76B 11.79B 2026-03
Gilead Sciences USD 2.68B 284M 2026-03
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Merck USD -1.88B 8.12B 2026-03
Myriad Genetics USD -3M 20.3M 2025-12
Pacira USD 4.62M 1.43M 2026-03
Perrigo USD 33.6M 50.8M 2026-03
Pfizer USD 4.99B 340M 2026-03
PTC Therapeutics USD 45.89M 127.51M 2026-03
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Sarepta Therapeutics USD 358.43M 768.52M 2026-03
Teva Pharmaceutical Industries USD 758M 181M 2026-03
Vertex Pharmaceuticals USD 1.14B 124.5M 2026-03
Xencor USD -77.86M 24.23M 2026-03
Zoetis USD 842M 7M 2026-03